DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Körper S, Grüner B, Zickler D. et al.
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients.
J Clin Invest 2022; e163657
Körper S, Grüner B, Zickler D. et al.
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients.
J Clin Invest 2022; e163657
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.